Albree Tower-Rader

11PUBLICATIONS
54CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Infant and child healthClinical chemistry (incl. diagnostics)Recommender systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 09, 2025
Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy.

Shogo Tamura, Keitaro Akita, Michael A Fifer

|Mar 31, 2025
Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial.

Milind Y Desai, Anjali Owens, Sara Saberi

|Jan 20, 2025
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP.

Itsuki Osawa, Keitaro Akita, Kohei Hasegawa

|Jan 13, 2025
Multimodality Imaging Evaluation of Diseases of the Pulmonic Valve and Right Ventricular Outflow Tract for the Adult Cardiologist.

Seán P Murphy, Sadia Sultana, Emily K Zern

|Dec 24, 2024
Echocardiographic Changes Following Surgical Myectomy in Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the SPIRIT-HCM Study.

Milind Y Desai, Natalie Szpakowski, Albree Tower-Rader

|Nov 18, 2024
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.

Milind Y Desai, Kathy Wolski, Anjali Owens

Pageof 2

Frequent Collaborators

3 joint publications

Mark Sherrid

3 joint publications

Anjali T Owens

3 joint publications

Jeffrey B Geske

3 joint publications

Andrew Wang